Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
208 Ergebnisse für "bayer" unter Somagenetix
UZH - Institut für Bildungsevaluation - Nicole Bayer
... Nicole Bayer, Dr. phil., studierte an der Universität Zürich Pädagogik, Betriebswirtschaftslehre ... verschiedenen Schulen und Stufen tätig. Im März 2010 schloss Nicole Bayer ihre Doktorarbeit zum Thema ... UZH - Institut für Bildungsevaluation - Nicole Bayer ... UZH - Institut für Bildungsevaluation - Nicole Bayer Home Hauptnavigation Suche Direkt zum Inhalt ... UZH - Institut für Bildungsevaluation - Nicole Bayer ...
Standardprüfungen Liechtenstein 2019: Zwischenbericht zur Durchführ...
... Verner, Martin ; Bayer, Nicole (2019). Standardprüfungen Liechtenstein 2019: Zwischenbericht zur ... zuhanden des Schulamtes Verner, Martin ; Bayer, Nicole (2019). Standardprüfungen Liechtenstein 2019 ... -0003-0154-9866 Bayer, Nicole Source of ORCID ID: Author Similar Publications Footer Contact University ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
178 Ergebnisse für "bayer" unter University of Zurich
UZH - Seminar für Griechische und Lateinische Philologie - Disserta...
... Theresa Bayer (mit Prof. Scholz) Abgeschlossene Co-Betreuungen von Prof. Cardelle ... . Stotz) Clara Wille (Prof. Stotz) Co-Betreuungen von Prof. Cardelle Theresa Bayer (mit Prof. Scholz ...
Wirkungen unterschiedlicher Modelle der Schuleingangsstufe auf den ...
... Entwicklungsstand: Erste Ergebnisse einer Längsschnittstudie Bayer, N ; Moser, U (2009). Wirkungen unterschiedlicher ... Schuleingangsstufe auf den Lern- und Entwicklungsstand: Erste Ergebnisse einer Längsschnittstudie Bayer, N ; Moser, U ... , Affiliations, Collaborations Bayer, N Moser, U Similar Publications Footer Contact University Library of Zurich ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
40 Ergebnisse für "bayer" unter University Hospital Zurich, Research and Education Office
Forschung der Klinik für Angiologie – Universitätsspital Zürich
... ) Bayer (unrestricted grant for the ARIVA trial) Concept Medical (unrestricted grant for the SirPAD trial ... Zurich International Society on Thrombosis and Hemostasis (ISTH) Bayer (unrestricted grant for the ARIVA ...
PowerPoint-Präsentation
... , Amgen, Astra Zeneca, AtriCure, Bayer, Biosense Webster, Biotronik, BMS, Boehringer Ingelheim, Boston ... (through institution): Bayer, Biotronik, Boston Scientific, Daiichi- Sankyo, Medtronic, Abbott o Ownership ... , Amgen, Astra Zeneca, AtriCure, Bayer, Biosense Webster, Biotronik, BMS, Boehringer Ingelheim, Boston ... (through institution): Bayer, Biotronik, Boston Scientific, Daiichi- Sankyo, Medtronic, Abbott o Ownership ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
27 Ergebnisse für "bayer" unter ETH Entrepreneurship
Enhancing Biodiversity & Resilience in Agriculture – World Food Sys...
... with Bayer and the International Food Policy Research Institute to develop nature-based solutions that ... and local perspectives. Bayer AG, as the funding agency, has strong interest in identifying practices ... researchers join forces with Bayer and the International Food Policy Research Institute to develop nature ... the USA, to provide both global and local perspectives. Bayer AG, as the funding agency, has strong ...
Thermal Tracer Tomography to Characterise Aquifer Heterogeneity - R...
... Contributors Examiner: Loew, Simon Examiner: Bayer, Peter Examiner: Brauchler, Ralph Examiner: Bour, Olivier ...
DISCO Pharmaceuticals Swiss GmbH
8952 Schlieren, Wagistrasse 25
Disco Pharmaceuticals is a young ETH spin-off company based in Zurich/Switzerland and Cologne/Germany. We leverage a novel mass spectrometric technology to investigate processes that are fundamental to cancer biology. We combine methodologies in cell biology, biochemistry, mass spectrometry with computational tools to identify proteins selectively expressed on cancer cells. Our ultimate goal is to develop innovative therapies for cancers with high unmet clinical need.
DISCO Pharmaceuticals Swiss GmbH
Wagistrasse 25
8952 Schlieren
2 Ergebnisse für "bayer" unter DISCO Pharmaceuticals Swiss GmbH
DISCO Pharmaceuticals launches as the surfaceome company with EUR 2...
... executives Dieter Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics ... , Dieter Weinand will join as Chairman of the Board. Dieter Weinand was previously the CEO of Bayer ... Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics), join the DISCO ... , Dieter Weinand will join as Chairman of the Board. Dieter Weinand was previously the CEO of Bayer ...
DISCO Pharmaceuticals – The surfaceome company
... former CEO of Bayer Pharma, is an experienced business leader with over 25 years of experience in the ... region, EMEA, Latin America and the US, for companies including Bayer, Pfizer, Bristol-Myers Squibb, and ... University of Bonn, Germany. Board of Directors Dieter Weinand Dieter Weinand Dieter, the former CEO of Bayer ... America and the US, for companies including Bayer, Pfizer, Bristol-Myers Squibb, and Sanofi. He has also ...
InCephalo AG
8952 Schlieren, Wagistrasse 21
InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, also called C-Lock, retains biologics, that are applied locally behind the blood brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrades them rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects). Especially the peripheral side effects still limit various promising candidates for the treatment of brain cancer or other neurological diseases.
InCephalo AG
Wagistrasse 21
8952 Schlieren
1 Ergebnisse für "bayer" unter InCephalo AG
News – InCephalo Therapeutics
... various other senior executive roles in companies such as Bayer, Novartis, AstraZeneca, GE Healthcare and ... AstraZeneca and Executive Director at Novartis and Bayer Pharmaceuticals. Lorenz obtained a Ph.D. in ... companies such as Bayer, Novartis, AstraZeneca, GE Healthcare and Syncona. Previously, he was Chief ... Bayer Pharmaceuticals. Lorenz obtained a Ph.D. in Biochemistry & Biophysics at University of Bayreuth in ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
4 Ergebnisse für "bayer" unter CSL Vifor
CSL Behring Donates 500 Million International Units of Coagulation ...
... without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring ... Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary ...
CSL Annual Report 2022 – Page 77
... .; AstraZeneca PLC; Bausch Health Companies Inc.; Bayer Aktiengesellschaft; Biogen Inc.; BioMarin Pharmaceutical ... Inc.; AstraZeneca PLC; Bausch Health Companies Inc.; Bayer Aktiengesellschaft; Biogen Inc.; BioMarin ...
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
6 Ergebnisse für "bayer" unter Standortförderung Kanton Zürich
Betreuung und Pflege zu Hause durch Angehörige: Analyse der aktuell...
... (Quelle: Höpflinger, F. Bayer-Oglesby, L. und Zumbrunn A. (2011)) Die durchschnittliche Lebenserwartung ... , Bundesamt für Statistik, 2010) (Quelle: Höpflinger, F. Bayer-Oglesby, L. und Zumbrunn A. (2011)) Für die ... (Quelle: Höpflinger, F. Bayer-Oglesby, L. und Zumbrunn A. (2011)) Die durchschnittliche Lebenserwartung ... , Bundesamt für Statistik, 2010) (Quelle: Höpflinger, F. Bayer-Oglesby, L. und Zumbrunn A. (2011)) Für die ...
Sicherheitsunternehmen mit Bewilligung des Kantons Zürich
... Security GmbH Binzholzstrasse 26 8636 Wald Stefan Bayer FERN Security GmbH Bösch 21 6331 Hünenberg Hugo ... Security GmbH Binzholzstrasse 26 8636 Wald Stefan Bayer FERN Security GmbH Bösch 21 6331 Hünenberg Hugo ...
CDR-Life AG
8810 Horgen, Tödistrasse 46
CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.
CDR-Life AG
Tödistrasse 46
8810 Horgen
1 Ergebnisse für "bayer" unter CDR-Life AG
Company - CDR-Life
... public at Euronext in 2009), Bayer and Johnson & Johnson’s Janssen-Cilag. Most recently, he served as ... 2009), Bayer and Johnson & Johnson’s Janssen-Cilag. Most recently, he served as head of business ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren